Home/Filings/4/0001628280-21-010023
4//SEC Filing

Donley Matthew Maxwell 4

Accession 0001628280-21-010023

CIK 0001600620other

Filed

May 11, 8:00 PM ET

Accepted

May 12, 4:34 PM ET

Size

4.4 KB

Accession

0001628280-21-010023

Insider Transaction Report

Form 4
Period: 2021-05-11
Donley Matthew Maxwell
Chief Operating Officer
Transactions
  • Purchase

    Common Stock

    2021-05-11$10.07/sh+9,900$99,7399,900 total

Issuer

Aurinia Pharmaceuticals Inc.

CIK 0001600620

Entity typeother

Related Parties

1
  • filerCIK 0001636642

Filing Metadata

Form type
4
Filed
May 11, 8:00 PM ET
Accepted
May 12, 4:34 PM ET
Size
4.4 KB